PharmEasy-Owned Thyrocare’s Q4 Profit Jumps 25.6% To INR 21.6 Cr

https://inc42.com/buzz/pharmeasy-owned-thyrocares-q4-profit-jumps-25-6-to-inr-21-6-cr/

* Q4 FY25 Profit: Up 25.6% YoY to INR 21.6 Cr, 14% growth QoQ.
* Revenue Growth: INR 187.2 Cr, 21.3% YoY growth, 12.8% QoQ growth.
* Total Revenue: INR 191.8 Cr, including other income (21.8% increase YoY).
* Franchise & Partnerships: 63% revenue from franchises; 16% growth in active franchises (11,249 total).
* Labs & Patients: 29 labs, 11% growth in patients (16.7 Mn total).
* Expenses: INR 143.9 Cr, 6.9% YoY rise, 1.4% QoQ rise.
* Annual Performance (FY25): Revenue INR 687.4 Cr (20.2% growth), Net Profit INR 90.8 Cr (30.6% growth).
* Ownership: Acquired by PharmEasy in 2021 for INR 4,546 Cr; API Holdings owns 66.1%.
* Future Plans: Expanding to international markets, starting with Tanzania.